194 related articles for article (PubMed ID: 16550511)
1. Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma.
Ozgönenel B; Moonka D; Savaşan S
Am J Hematol; 2006 Apr; 81(4):302. PubMed ID: 16550511
[No Abstract] [Full Text] [Related]
2. Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.
Stange MA; Tutarel O; Pischke S; Schneider A; Strassburg CP; Becker T; Barg-Hock H; Bastürk M; Wursthorn K; Cornberg M; Ott M; Greten TF; Manns MP; Wedemeyer H
Z Gastroenterol; 2010 Feb; 48(2):258-63. PubMed ID: 20127601
[TBL] [Abstract][Full Text] [Related]
3. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.
Perceau G; Diris N; Estines O; Derancourt C; Lévy S; Bernard P
Br J Dermatol; 2006 Nov; 155(5):1053-6. PubMed ID: 17034541
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
5. Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment?
Garcia-Rodriguez MJ; Canales MA; Hernandez-Maraver D; Hernandez-Navarro F
Am J Hematol; 2008 Aug; 83(8):673-5. PubMed ID: 18528824
[TBL] [Abstract][Full Text] [Related]
6. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
[No Abstract] [Full Text] [Related]
7. Diffuse large B-cell primary gastric lymphoma treated successfully with the CD20 monoclonal antibody (rituximab): a case with severe liver dysfunction due to liver cirrhosis and hepatocellular carcinoma.
Nakai S; Masaki T; Shintani T; Deguchi A; Kimura Y; Himoto T; Kurokohchi K; Watanabe S; Kuriyama S
Oncol Rep; 2005 Jun; 13(6):1065-8. PubMed ID: 15870922
[TBL] [Abstract][Full Text] [Related]
8. Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
Dillon R; Hirschfield GM; Allison ME; Rege KP
BMJ; 2008 Jul; 337():a423. PubMed ID: 18595895
[No Abstract] [Full Text] [Related]
9. Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient.
Aksoy S; Abali H; Kilickap S; Erman M; Kars A
Clin Lab Haematol; 2006 Jun; 28(3):211-4. PubMed ID: 16706940
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in diffuse large B-cell lymphoma.
Coiffier B
Clin Adv Hematol Oncol; 2004 Mar; 2(3):156-7. PubMed ID: 16166943
[No Abstract] [Full Text] [Related]
11. [A fatal case of a hepatitis B virus carrier with fulminant hepatic failure after cytotoxic chemotherapy for malignant lymphoma].
Kumagai K; Takagi T; Sakai C; Oguro M; Kawai S; Nakahori S; Yokosuka O; Ohtoh M
Rinsho Ketsueki; 1993 Dec; 34(12):1587-9. PubMed ID: 8295335
[TBL] [Abstract][Full Text] [Related]
12. [Progressive outer retinal necrosis in a patient with malignant lymphoma].
Takei Y; Usui N; Dobashi N; Hagino T; Okawa Y; Takahara S; Asai O; Kobayashi M
Rinsho Ketsueki; 2004 Mar; 45(3):250-1. PubMed ID: 15103942
[TBL] [Abstract][Full Text] [Related]
13. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
Sumi M; Ichikawa N; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2007 Jul; 48(7):571-5. PubMed ID: 17695307
[TBL] [Abstract][Full Text] [Related]
14. Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma.
Zinzani PL; Bendandi M; Gamberi B; Magagnoli M; Gherlinzoni F; Tura S
Haematologica; 2000 Apr; 85(4):437-8. PubMed ID: 10756377
[No Abstract] [Full Text] [Related]
15. [Pure red cell aplasia successfully treated with rituximab in a patient with relapsed diffuse large B-cell lymphoma].
Suzuki T; Kumagai T; Kitano A; Kubo H; Tabata M; Kimura Y; Miura O; Imai Y
Rinsho Ketsueki; 2007 Jan; 48(1):67-70. PubMed ID: 17313080
[TBL] [Abstract][Full Text] [Related]
16. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma.
Eur J Cancer Care (Engl); 2003 Dec; 12(4):306-7. PubMed ID: 14982308
[No Abstract] [Full Text] [Related]
17. [Measurement of rituximab concentration in the cerebrospinal fluid in CNS lymphoma].
Kikuchi A; Kawada H; Iwaki Y; Machida S; Tsuchiya T; Fukuda R; Hotta T
Rinsho Ketsueki; 2004 Dec; 45(12):1255-7. PubMed ID: 15678918
[TBL] [Abstract][Full Text] [Related]
18. [Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma].
Ono K; Iyama S; Matsunaga T; Sato T; Sato Y; Okuda T; Takada K; Kawano Y; Hayashi T; Miyanishi K; Sagawa T; Kobune M; Takimoto R; Kato J; Niitsu Y
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1509-12. PubMed ID: 17876158
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma.
Cho CH; Hwang WL; Cheng SB; Lee TY; Teng CL
Ann Hematol; 2011 Jan; 90(1):111-2. PubMed ID: 20407894
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of a combined rituximab chemotherapy during pregnancy.
Herold M; Schnohr S; Bittrich H
J Clin Oncol; 2001 Jul; 19(14):3439. PubMed ID: 11454895
[No Abstract] [Full Text] [Related]
[Next] [New Search]